Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 19767528)

1.

Endogenous regulation of cardiovascular function by apelin-APJ.

Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM, Ho YD, Chun HJ, Bernstein D, Ashley EA, Quertermous T.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1904-13. doi: 10.1152/ajpheart.00686.2009. Epub 2009 Sep 18.

2.

Translational promise of the apelin--APJ system.

Barnes G, Japp AG, Newby DE.

Heart. 2010 Jul;96(13):1011-6. doi: 10.1136/hrt.2009.191122. Review.

PMID:
20584856
3.

The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.

Japp AG, Newby DE.

Biochem Pharmacol. 2008 May 15;75(10):1882-92. doi: 10.1016/j.bcp.2007.12.015. Epub 2008 Jan 5. Review.

PMID:
18272138
4.

[Activity of apelin and APJ receptors on myocardial contractility and vasomotor tone].

Losano G, Penna C, Cappello S, Pagliaro P.

Ital Heart J Suppl. 2005 May;6(5):272-8. Review. Italian.

PMID:
15934423
5.

Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.

Falcão-Pires I, Leite-Moreira AF.

Rev Port Cardiol. 2005 Oct;24(10):1263-76. Review. English, Portuguese.

6.

Apelin and its receptor APJ in cardiovascular diseases.

Yu XH, Tang ZB, Liu LJ, Qian H, Tang SL, Zhang DW, Tian GP, Tang CK.

Clin Chim Acta. 2014 Jan 20;428:1-8. doi: 10.1016/j.cca.2013.09.001. Epub 2013 Sep 18. Review.

PMID:
24055369
7.

The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.

O'Carroll AM, Lolait SJ, Harris LE, Pope GR.

J Endocrinol. 2013 Sep 11;219(1):R13-35. doi: 10.1530/JOE-13-0227. Print 2013 Oct. Review.

8.

Emerging roles of apelin in biology and medicine.

Kleinz MJ, Davenport AP.

Pharmacol Ther. 2005 Aug;107(2):198-211. Review.

PMID:
15907343
9.

Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.

Lv D, Li H, Chen L.

Acta Biochim Biophys Sin (Shanghai). 2013 Jul;45(7):527-33. doi: 10.1093/abbs/gmt040. Epub 2013 Apr 14. Review.

PMID:
23588025
10.

Apelin and ACE2 in cardiovascular disease.

Kalea AZ, Batlle D.

Curr Opin Investig Drugs. 2010 Mar;11(3):273-82. Review.

PMID:
20178040
11.

Putative role for apelin in pressure/volume homeostasis and cardiovascular disease.

Charles CJ.

Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):1-10. Review.

PMID:
17266543
12.

[Apelin, a neuropeptide that counteracts vasopressin secretion].

Llorens-Cortès C, Beaudet A.

Med Sci (Paris). 2005 Aug-Sep;21(8-9):741-6. Review. French.

13.

Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension.

Kim J.

Mol Cells. 2014 Mar;37(3):196-201. doi: 10.14348/molcells.2014.2308. Epub 2014 Mar 3. Review.

14.

The apelinergic system: a promising therapeutic target.

Falcão-Pires I, Ladeiras-Lopes R, Leite-Moreira AF.

Expert Opin Ther Targets. 2010 Jun;14(6):633-45. doi: 10.1517/14728221003752743. Review.

PMID:
20350050
15.

The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.

Chapman NA, Dupré DJ, Rainey JK.

Biochem Cell Biol. 2014 Dec;92(6):431-40. doi: 10.1139/bcb-2014-0072. Epub 2014 Aug 20. Review.

PMID:
25275559
16.

[The APJ receptor: a new therapeutic approach in diabetic treatment].

Masri B, Dray C, Knauf C, Valet P, Castan-Laurell I.

Med Sci (Paris). 2015 Mar;31(3):275-81. doi: 10.1051/medsci/20153103013. Epub 2015 Apr 8. Review. French.

PMID:
25855281
17.

Apelin receptor: its responsiveness to stretch mechanisms and its potential for cardiovascular therapy.

Scimia MC, Blass BE, Koch WJ.

Expert Rev Cardiovasc Ther. 2014 Jun;12(6):733-41. doi: 10.1586/14779072.2014.911661. Epub 2014 May 5. Review.

PMID:
24794045
18.

The alternative heart: impact of alternative splicing in heart disease.

Lara-Pezzi E, Gómez-Salinero J, Gatto A, García-Pavía P.

J Cardiovasc Transl Res. 2013 Dec;6(6):945-55. doi: 10.1007/s12265-013-9482-z. Epub 2013 Jun 18. Review.

PMID:
23775418
19.

[The neuroprotective effect and mechanisms of Apelin/APJ system].

Wu F, Zhang QL.

Sheng Li Ke Xue Jin Zhan. 2013 Feb;44(1):39-44. Review. Chinese. No abstract available.

PMID:
23672000
20.

Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.

Yang P, Maguire JJ, Davenport AP.

Trends Pharmacol Sci. 2015 Jul 1. pii: S0165-6147(15)00117-0. doi: 10.1016/j.tips.2015.06.002. [Epub ahead of print] Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk